Analyze Your Search

Hints:

  • Action links for each search result record
    • Bookmark: Allows you to Bookmark the page for easy future retrieval 
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Follow" button to the right of the search box. 
Dermatology in the News
  Follow Topic   Edit Search
Your search returned 23 results
from the time period: last 30 days.
Sort by Relevance / Date Group By Source / No Grouping
ClinicalTrials.gov
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD) - Full Text View. Experimental: Group 1. Participants will receive dupilumab, dosing regimen 1. Drug: Dupilumab. Pharmaceutical form: Solution for injection in pre-filled syringe. Route of administration: Subcutaneous (SC.
Dermatology (2)
Atopic Dermatitis (2)
ClinicalTrials.gov
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Severe Atopic Dermatitis (Liberty AD PRESCHOOL) - Full Text View. Primary Outcome Measures. Part A: Pharmacokinetic (PK) parameter - Maximum observed concentration (Cmax) [ Time Frame: Baseline to week 4. Peak dupilumab concentration in serum following single-dose administration.
Dermatology (2)
Atopic Dermatitis (2)
ClinicalTrials.gov
Animated Video Consultation for Reducing Pre-Operative Anxiety in Outpatient Dermatologic Surgery - Full Text View. Primary Outcome Measures. Pre-operative anxiety levels assessed via questionnaire [ Time Frame: 1 day. This will be an randomized controlled pilot study. Subjects will be randomized to either receive an animated video along with conventional consultation OR receive a conventional consultation only.
Prostate Cancer News
... 2017 /EINPresswire.com/ -- The market for drugs to treat skin conditions is growing at nearly 7% year on year in ... Dermatology drugs are used for the treatment of skin conditions such as dermatitis (including eczema), rosacea, hyperhidrosis, androgenic alopecia, onychomycosis, hair loss, acne, immune disorders (including psoriasis), microbial infections (bacterial, fungal, and viral), vascular and pigmented lesion removal, common warts, seborrheic keratosis, and other skin diseases ...
Dermatology (9), Oncology (3), Muscular and Skeletal Diseases (2)
Skin Diseases (2), Psoriasis (2), Rosacea (1)
Prostate Cancer News
Topical Treatment Shown Effective in Treating Larger Areas of Skin Affected by Cancer Precursor - Prostate Cancer News Today ... SKIN, Ingenol Mebutate 0.06% Gel for Field Treatment of Actinic Keratosis on 250 cm2 of Skin on Trunk and Extremities: A Randomized Dose-Finding Trial ... Long Island Skin Cancer and Dermatologic Surgery.
Oncology (5)
Actinic Keratosis (5), Neoplasms (2), Skin Neoplasms (2)
News-Medical.net
Children who have atopic dermatitis at age one more likely to develop asthma and ... at one year old who have eczema or atopic dermatitis (AD) and are sensitized to an allergen are seven ... long been known that infants with eczema or atopic dermatitis (AD) are more likely to develop asthma and allergic ...
Dermatology (4)
Asthma (10), Food Hypersensitivity (7), Atopic Dermatitis (4)
ClinicalTrials.gov
A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® (Tazarotene) Cream, 0.1% in the Topical Treatment of Acne Vulgaris - Full Text View. A study for Subjects with mild to moderate facial acne vulgaris. Subjects will be randomized to treatment with either DFD-03 (tazarotene) Lotion 0.1%, Tazorac (tazarotene) Cream, 0.1%, Vehicle ...
Dermatology (3)
Acne Vulgaris (3)
ClinicalTrials.gov
... investigate the molecular mechanisms of action of photo(chemo)therapy in skin diseases, including psoriasis, cutaneous T-cell lymphoma, other lymphoproliferative disorders of the skin, eczema, lichen planus, prurigo/pruritus, polymorphic light eruption, mastocytosis ... response to treatment will be assessed with scores including dermatological quality of life (DLQI) and disease-specific scores such ...
Dermatology (3)
Pruritus (5), Skin Diseases (3), Psoriasis (2)
CNN (United States)
Epidermolysis bullosa makes the skin incredibly susceptible to infections, and in the case of 7-year-old Hassan ... Seeing him 18 months after the initial surgery with an intact skin is incredible because he has been in the ICU ... Obviously, gene therapy of the skin cannot correct them, and these issues have to be ...
Stem Cell Research (5), Infectious Diseases (2), Muscular and Skeletal Diseases (1)
Epidermolysis Bullosa (9), Infections (3), Sepsis (1)
FierceMedicalDevices
... asthma success, AstraZeneca and Amgen’s tezepelumab misses in atopic dermatitis... PDF) the primary endpoint in a phase 2a atopic dermatitis trial... The monoclonal antibody fared worse in the atopic dermatitis phase 2a. Investigators enrolled 155 adults with moderate-to-severe atopic dermatitis and randomized them to receive twice-monthly subcutaneous injections ...
Dermatology (10)
Atopic Dermatitis (10), Asthma (8), Eczema (1)
News-Medical.net
This condition leaves the skin thin and papery and easily breakable... then, the child has received a new genetically modified skin covering 80 percent of his body in several successful surgeries ... He was missing large areas of skin that made him exceptionally vulnerable to infections and other complications ... Tags: Children, Dermatology, DNA, Epidermis, Epidermolysis Bullosa, Gene, Gene Therapy, Genetic, Hospital, Laboratory, Palliative Care, Protein, Skin, Skin Graft, Soccer, Virus ...
Stem Cell Research (2), Dermatology (1)
Junctional Epidermolysis Bullosa (1), Infections (1), Epidermolysis Bullosa (1)
ClinicalTrials.gov
Treatment of Acne Scars With Erbium:Yttrium Aluminum Garnet (Er:YAG) Laser Examined Under OCT - Full Text ... laser at a 2940nm wavelength (Alma - Harmony XL Laser) and parameters corresponding with their acne scar severity... at a 2940nm wavelength is used for ablative laser resurfacing as well as treating acne scars.
Dermatology (4)
Acne Vulgaris (4)
ClinicalTrials.gov
A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis - Full Text View. Primary Outcome Measures. Proportion of Participants with a Response of Investigator's Global Assessment (IGA) 0 or 1 at 16 Weeks [ Time Frame: 16 Weeks. Proportion of participants achieving IGA 0 or 1 at 16 weeks. Proportion of Participants with a Response of IGA 0 or 1 ...
Dermatology (2)
Atopic Dermatitis (2), Eczema (1)
ClinicalTrials.gov
... blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman... Acne vulgaris of adult woman has increased over the past ... The physiopathology of adult woman acne is distinguished from the teenager one by essentially 2 ... lower than 200mg/day), spironolactone can be effective against acne... randomized study spironolactone vs cyclines which remains the moderate acne reference treatment and to demonstrate the superiority of spironolactone's ...
Dermatology (6), Infectious Diseases (1)
Acne Vulgaris (6), 46,XX Gonadal Dysgenesis (2), Phlebitis (1)
ClinicalTrials.gov
... Baricitinib (LY3009104) in Adults With Moderate to Severe Atopic Dermatitis - Full Text View... Proportion of Participants Achieving SCORing Atopic Dermatitis 75 (SCORAD75) [ Time Frame: 16 Weeks... in the Score of Item 2 of the Atopic Dermatitis Sleep Scale (ADSS) [ Time Frame: Baseline, 16 Weeks... Proportion of Participants Developing Skin Infections Requiring Antibiotic Treatment [ Time Frame: 16 Weeks. Proportion of participants developing skin infections requiring antibiotic treatment.
Dermatology (7), Infectious Diseases (2), Neuroscience (1)
Atopic Dermatitis (6), Infections (2), Eczema (2)
ClinicalTrials.gov
... of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria - Full Text View... Weekly Urticaria Activity Score (UAS7) [ Time Frame: 12 weeks... mg have a greater reduction from baseline in weekly urticaria activity score (UAS7) at Week 12, compared to placebo ... of Xolair ® (omalizumab) in Chinese patients with chronic spontaneous urticaria (CSU) who remain symptomatic despite antihistamine treatment The purpose ...
Cardiovascular Diseases (1), Dermatology (1)
Urticaria (5), Tuberculosis (1)
United Press International - UPI (United States)
... the drug anabasum was effective at treating a rare skin condition... with dermatomyositis, or DM, a rare and often incurable skin condition that causes symptoms ranging from a skin rash and muscle weakness to fevers, shortness of breath ... 11 patients who were given anabasum, with less severe skin disease and better quality of life being reported.
Muscular and Skeletal Diseases (1), Dermatology (1), Anti-Obesity and Weight Loss (1)
Exanthema (1), Photophobia (1), Lung Diseases (1)
News-Medical.net
... the drug improved during the trial, with less severe skin disease and better patient-reported quality of life and symptom ... Dermatomyositis is an inflammatory disease that causes a rash on the skin and is frequently associated with muscle weakness ... principal investigator Victoria P. Werth, MD, a professor of Dermatology at Penn and the Chief of Dermatology at the Corporal Michael J. Crescenz VA Medical Center ...
Dermatology (3), Muscular and Skeletal Diseases (1), Anti-Obesity and Weight Loss (1)
Dermatomyositis (3), Lung Diseases (1), Dizziness (1)
ClinicalTrials.gov
Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis Patients - Full Text View... Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with pruritus... evolution of serum IgE levels, the EASI (Eczema Area and Severity Index) and SCORAD (Scoring Atopic Dermatitis) severity scores and pruritus in them.
Dermatology (4)
Pruritus (5), Atopic Dermatitis (4), Skin Diseases (1)
ClinicalTrials.gov
Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or Lupus - Full Text View... Intervention of patient centered care situation and health-related quality of life of patients with Psoriasis, Urticaria or Lupus erythematodes from non-urban practices vs urban practises. Identification of relevant health-related quality of life parameters of these patients.
Dermatology (5), Immune System Diseases (3)
Psoriasis (5), Urticaria (3)
ClinicalTrials.gov
Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients - Full Text View... The aim was to determine whether neurologic disorders, especially dementia, influences outcome and mortality of patients with bullous pemphigoid.
Neuroscience (7)
Dementia (5), Bullous Pemphigoid (3), Nervous System Diseases (1)
ClinicalTrials.gov
Skin Disease and Pulmonary Mortality After Transplantation - Full Text View. Primary Outcome Measures. Crude Pulmonary Mortality [ Time Frame: 10 years. The Primary outcome; Crude pulmonary mortality was defined as lethal outcome of pulmonary disease and comprised IPS including interstitial pneumonitis with or without pulmonary infection, but also pneumonia and undefined respiratory insufficiency or interstitial fibrosis.
Infections (3), Pneumonia (3), Skin Diseases (2)
ClinicalTrials.gov
Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification - Full Text View. Experimental: Nd: YAG laser posterior capsulotomy. Posterior capsulotomy was performed by using Nd: YAG laser and macular pigment optical density, intra ocular pressure, choroidal thickness, macular thickness and anterior chamber parameters were measured before Nd: YAG laser, at 1 week ...
Capsule Opacification (2)